Auxly Cannabis GroupCBWTF -3.85%36 Return-on-Tangible-Equity is 9.11% as of Mar. 2026. GuruFocus rates CBWTF with a GF Score™ of 36/100 and a GF Value™ of $0.03 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 895 Drug Manufacturers companies, Auxly Cannabis Group ranks better than 83.91% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Auxly Cannabis Group's annualized net income for the quarter that ended in Mar. 2026 was $10.1 Mil. Auxly Cannabis Group's average shareholder tangible equity for the quarter that ended in Mar. 2026 was $111.0 Mil. Therefore, Auxly Cannabis Group's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 9.11%.
The historical rank and industry rank for Auxly Cannabis Group's Return-on-Tangible-Equity or its related term are showing as below:
CBWTF'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -163.92 Med: -58.77 Max: 35.58
Current: 25.29
During the past 13 years, Auxly Cannabis Group's highest Return-on-Tangible-Equity was 35.58%. The lowest was -163.92%. And the median was -58.77%.
CBWTF's Return-on-Tangible-Equity is ranked better than 83.91% of 895
companies
in the Drug Manufacturers industry
Industry Median: 7.89
vs CBWTF: 25.29
Auxly Cannabis Group (OTCPK:CBWTF) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Auxly Cannabis Group Return-on-Tangible-Equity Related Terms
Auxly Cannabis Group Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Auxly Cannabis Group's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Auxly Cannabis Group Return-on-Tangible-Equity Chart
CBWTF vs ZTS, UTHR: Return-on-Tangible-Equity Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Auxly Cannabis Group's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Auxly Cannabis Group Return-on-Tangible-Equity vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Auxly Cannabis Group's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Auxly Cannabis Group's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 9.11% mean?
Auxly Cannabis Group (CBWTF) has a Return-on-Tangible-Equity of 9.11% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Auxly Cannabis Group and its competitors. According to the industry distribution chart, Auxly Cannabis Group ranks #144 out of 895 companies in the Drug Manufacturers industry, placing it in the top 16.1%.
Is Auxly Cannabis Group's Return-on-Tangible-Equity too high?
Auxly Cannabis Group's current Return-on-Tangible-Equity is 9.11%. The Drug Manufacturers industry median Return-on-Tangible-Equity is 7.89. Auxly Cannabis Group's value of 9.11% is 15.5% above this industry median. Based on the distribution chart, Auxly Cannabis Group ranks #144 out of 895 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Auxly Cannabis Group has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Auxly Cannabis Group's Return-on-Tangible-Equity compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Auxly Cannabis Group ranks #144 out of 895 companies for Return-on-Tangible-Equity. This places Auxly Cannabis Group in the top 16% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 7.89. Auxly Cannabis Group's value of 9.11% is 15.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Drug Manufacturers company?
The median Return-on-Tangible-Equity among Drug Manufacturers companies is 7.89, based on 895 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Auxly Cannabis Group's current Return-on-Tangible-Equity of 9.11% is 15.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Auxly Cannabis Group and its competitors. For the Drug Manufacturers industry, the median Return-on-Tangible-Equity is 7.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Auxly Cannabis Group's current Return-on-Tangible-Equity is 9.11%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Auxly Cannabis Group stock overvalued right now?
Based on GuruFocus' analysis, Auxly Cannabis Group (CBWTF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.03, compared to a current price of $0.12 — trading 308% above its estimated fair value. The current Return-on-Tangible-Equity is 9.11% and 15.5% above the Drug Manufacturers industry median of 7.89. Auxly Cannabis Group's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Auxly Cannabis Group (CBWTF), the current Return-on-Tangible-Equity is 9.11% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Auxly Cannabis Group (CBWTF) Overvalued in 2026?
Based on GuruFocus' analysis, Auxly Cannabis Group stock appears to be overvalued.
The current stock price of $0.12 is trading 308% above its estimated GF Value™ of $0.03.
GuruFocus considers Auxly Cannabis Group to be Significantly Overvalued.
Key valuation signals for CBWTF:
Return-on-Tangible-Equity: 9.11%
GF Value™: $0.03 vs. price of $0.12 (308% above fair value)
Industry Position: 15.5% above the Drug Manufacturers median (#144 of 895)
No single metric tells the full story. See the CBWTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Auxly Cannabis Group Inc is a consumer-packaged-goods company in the cannabis products market. The company has created a portfolio of brands designed for a broad market of cannabis consumers, with differentiation in price points across targeted consumer segments. Its product portfolio comprises dried cannabis, fresh cannabis, cannabis plants, cannabis seeds, cannabis oil, edible cannabis, cannabis extracts, and cannabis topicals, among others, which are marketed through brands like Parcel, Black Forty, Foray, Dosecann, and Kolab Project.
36GF Score
Get the complete analysis for CBWTF
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CBWTF has been successfully added to your 
